Metabolism News and Research

Latest Metabolism News and Research

Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease

Mount Sinai School of Medicine is one of 12 sites nationwide participating in the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease. The study is the first multicenter neurosurgical intervention in Alzheimer's research in the U.S.

18 Nov 2009

CONTOUR USB meter available for purchase through Walgreens online pharmacy

Bayer's CONTOUR® USB meter, the first blood glucose monitor that connects directly to a PC or MAC -- providing users with instant access to information and trends about their blood sugar levels -- is now available for purchase through Walgreens online pharmacy and will soon also be available online through CVS and Walmart.

18 Nov 2009

Genzyme and Isis Pharmaceuticals announce phase 3 study data of mipomersen

Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with homozygous familial hypercholesterolemia (hoFH) were presented today at the American Heart Association’s Scientific Sessions.

17 Nov 2009

VCU and RAA have improved resuscitation and survival rates for cardiac arrest patients

Virginia Commonwealth University Medical Center and the Richmond Ambulance Authority have improved resuscitation and survival rates dramatically for cardiac arrest patients by training and equipping paramedics to begin lowering a patient's body temperature in the field during resuscitation and following up at the hospital with a host of high-tech strategies to improve the odds of survival.

17 Nov 2009

Roche receives EUA from FDA for its RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 virus

Roche`s RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 influenza virus has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). The Roche kit detects RNA from the 2009 H1N1 influenza A virus and allows rapid and accurate identification of patients infected with this virus.

17 Nov 2009

Mount Sinai School of Medicine to participate in Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease

17 Nov 2009

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

NovaDel Pharma Inc. today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture ZolpiMist™ in the United States and Canada. ZolpiMist™ is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

16 Nov 2009

Source of arsenic contamination of drinking water in Bangladesh found by MIT researchers

Researchers in MIT's Department of Civil and Environmental Engineering believe they have pinpointed a pathway by which arsenic may be contaminating the drinking water in Bangladesh, a phenomenon that has puzzled scientists, world health agencies and the Bangladeshi government for nearly 30 years. The research suggests that human alteration to the landscape, the construction of villages with ponds, and the adoption of irrigated agriculture are responsible for the current pattern of arsenic concentration underground.

16 Nov 2009

Columbia University Medical Center presents the 2009 Naomi Berrie Awards

Columbia University Medical Center will present the 2009 Naomi Berrie Awards to a nationally recognized diabetes researcher, and a promising young investigator, for their outstanding achievements in diabetes research.

16 Nov 2009

Phase I clinical study for ETC-1002 commenced

Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.

16 Nov 2009

Sensible Nutrition selected as Fitcorp's new nutrition partner

Fitcorp has selected Sensible Nutrition as their new nutrition partner. Fitcorp understands that nutrition is a major component of fitness and health and wants their members to have the ability to meet with Sensible Nutrition’s nationally renowned registered dietitians (RDs).

13 Nov 2009

New book 'Thinking in Circles About Obesity' presents a novel approach to address weight crisis

Low-carb-low-fat-high-protein-high-fiber-Americans are food-savvy, label-conscious, calorie-aware - and still gaining weight in spite of all their good intentions. Worse still, today's children run the risk of a shorter life expectancy than their parents.

13 Nov 2009

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.

13 Nov 2009

Gene within the pancreas affecting insulin secretion discovered

How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities. Their work opens the way for a new understanding of possible paths to battle diabetes and diabetes-related health problems, which are on the rise all over the world.

12 Nov 2009

Gene variants which influence insulin metabolism can also affect birth weight

Low birth weight increases the risk of developing type 2 diabetes later in life. Until recently scientists had attributed this to maternal malnutrition during pregnancy. However, now it seems that genetic background may also play a major role. A research team of Technische Universität München and Helmholtz Zentrum München has now demonstrated, that gene variants which influence insulin metabolism can also affect birth weight.

12 Nov 2009

Dark chocolates reduce stress levels

The "chocolate cure" for emotional stress is getting new support from a clinical trial published online in ACS' Journal of Proteome Research. It found that eating about an ounce and a half of dark chocolate a day for two weeks reduced levels of stress hormones in the bodies of people feeling highly stressed. Everyone's favorite treat also partially corrected other stress-related biochemical imbalances.

12 Nov 2009

New policies to decrease the public's exposure to EDCs; AMA to work with federal government

The American Medical Association's (AMA) House of Delegates adopted a resolution calling on the AMA to work with the federal government to enact new federal policies to decrease the public's exposure to endocrine-disrupting chemicals (EDCs).

11 Nov 2009

Tips to cut calories before Christmas time

It's official, everyone is getting ready for the Christmas Party Season. Research published this week from British Lion Eggs stated that 6 out of 10 women will be slimming down to fit into those LBDs from now until December in order to look their very shimmering best!

11 Nov 2009

Researchers identify cause that leads to age-related hearing loss

Age-related hearing loss is the most common sensory disorder among the elderly. But scientists are still trying to figure out what cellular processes govern or contribute to the loss.

11 Nov 2009

ImmunoGen to present IMGN901 clinical data at AACR-NCI-EORTC International Conference

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that several ImmunoGen poster presentations will be made at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held in Boston, MA, on November 15-19, 2009.

10 Nov 2009

Metabolism News and Research

Latest Metabolism News and Research

Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease

CONTOUR USB meter available for purchase through Walgreens online pharmacy

Genzyme and Isis Pharmaceuticals announce phase 3 study data of mipomersen

VCU and RAA have improved resuscitation and survival rates for cardiac arrest patients

Roche receives EUA from FDA for its RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 virus

Mount Sinai School of Medicine to participate in Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

Source of arsenic contamination of drinking water in Bangladesh found by MIT researchers

Columbia University Medical Center presents the 2009 Naomi Berrie Awards

Phase I clinical study for ETC-1002 commenced

Sensible Nutrition selected as Fitcorp's new nutrition partner

New book 'Thinking in Circles About Obesity' presents a novel approach to address weight crisis

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

Gene within the pancreas affecting insulin secretion discovered

Gene variants which influence insulin metabolism can also affect birth weight

Dark chocolates reduce stress levels

New policies to decrease the public's exposure to EDCs; AMA to work with federal government

Tips to cut calories before Christmas time

Researchers identify cause that leads to age-related hearing loss

ImmunoGen to present IMGN901 clinical data at AACR-NCI-EORTC International Conference

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut